Applied Materials vs. AMD: Which AI Semiconductor Stock Is a Better Buy in 2026?

Applied Materials is presented as the preferred 2026 investment over AMD, supported by a lower 23.4x forward P/E versus AMD's 39.5x and accelerating guidance implying roughly 50% year-over-year sales growth for its October quarter. AMD delivered stronger 2025 growth, with revenue up 34.3% to $34.6B, but its richer valuation, expected growth deceleration, potential warrant dilution equal to up to 20% of shares outstanding, and an $8.2B all-stock World Labs acquisition raise per-share execution risks. Applied Materials generated $28.4B of fiscal-2025 revenue and $7.0B of net income, though China accounted for about 30% of sales and the company paid $252.5M to settle U.S. export-control allegations.

Analysis

The relevant inflection is not absolute AI demand but the migration from a narrow accelerator buildout to broader wafer-fab-equipment intensity. If AMAT's near-term growth outlook converts to orders rather than shipment pull-forwards, operating leverage and service attach should support upward EPS revisions over the next 1-3 months; this is a cleaner mechanism than AMD's need to translate large customer commitments into profitable, per-share GPU revenue. TSM is the key read-through beneficiary, while ASML and LRCX are likely secondary beneficiaries of a sustained leading-edge and advanced-packaging capex cycle.

AMD's customer-linked warrants make headline contract value an incomplete measure of shareholder value. The economic trade-off can be attractive if GPU volumes generate sufficient gross profit, but potential dilution raises the required revenue and margin outcome for EPS accretion; investors should model fully diluted shares rather than use current-share consensus estimates. This creates a 6-18 month risk that AMD's multiple compresses even with strong reported revenue if MI-series mix, gross margin, or dilution-adjusted EPS disappoints.

AMAT is not defensively insulated: China exposure makes its earnings quality unusually sensitive to rule changes, license enforcement, and customer substitution toward domestic Chinese equipment suppliers. The recent settlement reduces one historical overhang but does not lower forward policy risk; a tightening of U.S. restrictions could turn a growth revision cycle into an order-cancellation narrative quickly. Contrarianly, the apparent valuation discount may already reflect this geopolitical earnings volatility, so the pair works best only if AMAT's order visibility improves outside China.

Near term, the market may be underpricing the distinction between revenue growth and per-share value creation. A sustained AMAT premium requires evidence that its backlog and services growth are broad-based, while AMD needs proof that contracted GPU deployments are shipping on schedule, carry accretive margins, and offset dilution; absent that proof, AMD remains more exposed to a crowded AI-capex de-rating than its revenue headline suggests.

Key Decisions for Investors

• Initiate a 3-6 month market-neutral pair: long AMAT / short AMD, sized dollar-neutral. Thesis is relative multiple compression in AMD versus upward AMAT earnings revisions; target 15-20% relative return. Exit if AMD raises gross-margin guidance while providing a fully diluted EPS bridge showing warrant-related dilution is offset, or if AMAT cuts its next-quarter revenue outlook materially.
• Add TSM on weakness rather than chase AMAT after a sharp move: TSM offers the cleaner volume capture from AI compute demand without AMAT's direct China-equipment policy concentration. Use a 6-12 month horizon; reassess if leading-edge utilization, advanced-packaging capacity plans, or hyperscaler capex guidance soften.
• Treat AMD customer-contract announcements as an alert, not a standalone buy catalyst. Before adding exposure, require disclosed shipment cadence, MI-series gross-margin trajectory, and an updated diluted-share-count framework; failure to provide these by the next two earnings cycles is a signal to maintain the relative short.
• Hedge AMAT-specific policy risk with defined-risk downside protection around Commerce Department rulemaking or earnings: buy 3-6 month AMAT put spreads financed selectively after volatility declines. The hedge is warranted if China revenue remains near current concentration; remove it if management demonstrates replacement demand from non-China customers and stable backlog conversion.